Venus Remedies receives patent for antibiotic Vancoplus
Patent, granted by Indian Patent Office, is valid till 2025
BS B2B Bureau B2B Connect | Panchkula, Haryana
Venus Remedies’s manufacturing facility
The total global market size of products used for treating MRSA-associated infections is estimated around $ 9 billion. At present, this market is growing at 4.8 percent, which is estimated to go up to 12.4 percent by 2017. In India, Vancoplus is projected to cater to a market of Rs 214 crore by 2018-19.
Venus Remedies has received patents for Vancoplus from more than 18 countries, including USA, Japan, South Africa, New Zealand, Ukraine and Australia. The company has announced that it is holding discussions with some multinational companies for the out-licencing of this product.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 10 2015 | 10:45 AM IST